VOGLISUG-TRIO 0.2 TABS
MRP: 1,630
Packaging: 10x10
Pack Type: tablet
Composition:
Voglibose IP 0.2mg + Gliclazide IP 80mg + Metformin Hydrochloride IP 500mg
Indication:
Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy
Description:
Voglibose IP 0.2mg + Gliclazide IP 80mg + Metformin Hydrochloride IP 500mg is an effective triple-combination oral antidiabetic medication designed to manage type 2 diabetes mellitus. This formulation combines three complementary agents to target different aspects of blood glucose regulation:
Voglibose (0.2mg): An alpha-glucosidase inhibitor that slows carbohydrate digestion and absorption, helping control postprandial (after-meal) blood sugar spikes.
Gliclazide (80mg): A sulfonylurea that stimulates pancreatic beta cells to increase insulin secretion, aiding in blood glucose reduction.
Metformin Hydrochloride (500mg): A biguanide that reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues.
Together, these agents provide comprehensive control of both fasting and post-meal blood glucose levels, improving overall glycemic control and reducing HbA1c. This medication is ideal for patients who require combination therapy beyond monotherapy for better diabetes management.
Tags:
- Controls both fasting and postprandial blood glucose
- Combines three mechanisms for effective glucose lowering
- Helps reduce HbA1c and maintain stable sugar levels
- Improves insulin secretion and sensitivity
- Convenient oral dosing enhances patient compliance
- Reduces risk of diabetes complications
Usage Information
Dosage
Typically, take one tablet once or twice daily with meals Swallow whole with water; do not crush or chew Follow your doctor’s instructions strictly Do not skip meals to avoid hypoglycemia
Side Effects
Hypoglycemia (low blood sugar) Gastrointestinal issues: nausea, bloating, diarrhea Headache Skin rash or allergic reactions (rare) Lactic acidosis (very rare but serious, related to Metformin)
Contraindications
Allergy to Voglibose, Gliclazide, or Metformin Type 1 diabetes or diabetic ketoacidosis Severe renal or hepatic impairment History of lactic acidosis Gastrointestinal obstruction or inflammatory bowel diseases Pregnancy and breastfeeding unless prescribed
Availability
Voglibose Gliclazide Metformin combination Triple therapy for type 2 diabetes Gliclazide 80mg Metformin 500mg Voglibose 0.2mg Diabetes medicine for post-meal sugar control Oral antidiabetic triple drug tablet Type 2 diabetes blood sugar control Sulfonylurea biguanide combination Postprandial glucose management medicine Voglibose based diabetes treatment Comprehensive diabetes control tablet